BIODESIX INC 3, filed Jul 6, 2023: form3.xml
SEC Form 3
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 07/03/2023 |
3. Issuer Name and Ticker or Trading Symbol
BIODESIX INC [ BDSX ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 4,390 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Options (Right to buy) | (1) | 02/22/2031 | Common Stock | 16,000 | 20.67 | D | |
| Stock Options (Right to buy) | (2) | 03/09/2032 | Common Stock | 11,734 | 2.29 | D | |
| Stock Options (Right to buy) | (2) | 02/28/2033 | Common Stock | 52,034 | 2 | D | |
| Restricted Stock Units | (4) | (4) | Common Stock | 6,619(4) | (3) | D | |
| Restricted Stock Units | (5) | (5) | Common Stock | 814(5) | (3) | D | |
| Restricted Stock Units | (6) | (6) | Common Stock | 18,776 | (3) | D | |
| Explanation of Responses: |
| 1. This option vested 40% on February 23, 2023, and the remaining 60% in 36 successive, equal monthly installments measured from February 23, 2023. |
| 2. This option is fully vested. |
| 3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| 4. Represents RSUs remaining from an initial grant of 9,627 RSUs that vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. |
| 5. Represents RSUs remaining from an initial grant of 4,885 RSUs that vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. |
| 6. These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. |
| Remarks: |
| Exhibit List: Exhibit 24 - Power of Attorney |
| /s/ Robin H. Cowie as Attorney-in-Fact for Chris Vazquez | 07/06/2023 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||